-
July 02, 2012
Human Genome Sciences, Inc. (HGSI) once again rejected GlaxoSmithKline's (GSK) $13 per share tender offer of ...
-
June 29, 2012
Perrigo Co. (PRGO) recently announced that it had received US Food and Drug Administration (FDA) approval for its ...
-
June 27, 2012
New York, June 27th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) are trading
very close to ...
-
June 27, 2012
Looking across the pond at the UK, one can't help but be attracted to some of the opportunities.
-
June 22, 2012
Novo Nordisk (NVO) recently announced that it is planning to initiate a phase III global development program, ...
-
June 22, 2012
Roche Holdings Ltd. (RHHBY) recently announced positive results on Perjeta (pertuzumab) from its phase III Cleopatra ...
-
June 19, 2012
We have maintained our Neutral recommendation on Theravance, Inc. (THRX) with a target price of $20.00 per share. ...
-
June 18, 2012
Human Genome Sciences, Inc. (HGSI) recently announced July 16, 2012 as the date for the submission of definitive ...
-
June 13, 2012
GlaxoSmithKline (GSK) recently announced that its subsidiary, Stiefel, has entered into an agreement with Basilea ...
-
June 12, 2012
GlaxoSmithKline plc (GSK) and XenoPort, Inc. (XNPT) recently announced that their drug, Horizant, has been approved ...
-
June 12, 2012
Roche Holdings Ltd.'s (RHHBY) subsidiary Genentech received some good news recently when the US Food and Drug ...
-
June 12, 2012
Human Genome Sciences, Inc. (HGSI) recently responded to GlaxoSmithKline plc's (GSK) extension of its unsolicited ...
-
June 08, 2012
Alexandria Real Estate Equities, Inc. (ARE), a real estate investment trust (REIT), recently entered into long-term ...
-
June 04, 2012
New York, June 4th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) closed the trading session at ...
-
May 17, 2012
It was revealed on Thursday that Human Genome Sciences (NASDAQ: HGSI) is in talks with, in its own words "major" ...
-
May 09, 2012
It's a sad fact that diabetes is becoming an increasingly commonplace disease, so at least it's encouraging that ...
-
May 09, 2012
Wednesday, May 9, 2012
It's all about Greece. Today's trading action may not be as volatile as the one on ...
-
May 03, 2012
The pharmaceutical giant reported decent first quarter results late in April 2012. However, It will likely be some ...
-
April 26, 2012
There’s no one place for growth any longer, so it pays to diversify across world markets and few funds do it ...
-
April 24, 2012
When the pharmaceutical giant GlaxoSmithKline stepped up to the plate with a $13 a share offer for Human Genome ...
